Clinical Trial Update: A Trial of a Walter Reed Army Institute of Research (WRAIR) Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy US Adults [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting results for a Walter Reed Army Institute of Research live attenuated tetravalent dengue vaccine in healthy adults, with GlaxoSmit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue

Drugs mentioned

• WRAIR live attenuated tetravalent dengue vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Dengue | Phase 2 | Status: COMPLETED | Results posted: 2019-02-19